BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...

Key rules on Medicare Advantage, telehealth and the No Surprises Act likely will be left for the Trump administration to ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Amgen CEO Robert Bradway said the company's obesity drug could find its space in the market due to once-monthly dosing and ...

More than half of respondents to a survey were unaware that bariatric surgery may improve some women’s chances of getting ...